Huawei Xia
Impact in
-
- Ferroptosis and cancer prognosis
Papers in
-
- Inflammasome and immune disorders 2
-
- IL-33, ST2, and ILC Pathways 2
- Immune cells in cancer 1
- Co-authors
- Fuping You (4 shared papers)Lili Cao (3 shared papers)Qi Liang (1 shared paper)Weizhi Nie (1 shared paper)Yishan Su (1 shared paper)Shengde Liu (2 shared papers)Xiao Wang (1 shared paper)Hongqiang Du (2 shared papers)
In The Last Decade
Huawei Xia
8 papers receiving 102 citations
Peers
Comparison fields: 5 of 48
- Immunology 25
- Pulmonary and Respiratory Medicine 30
- Molecular Biology 54
- Cancer Research 11
- Infectious Diseases 13
Countries citing papers authored by Huawei Xia
This map shows the geographic impact of Huawei Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huawei Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huawei Xia more than expected).
Fields of papers citing papers by Huawei Xia
This network shows the impact of papers produced by Huawei Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huawei Xia. The network helps show where Huawei Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Huawei Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 30 | |
| 2 | 2021 | 16 | |
| 3 | 2023 | 13 | |
| 4 | 2021 | 12 | |
| 5 | 2021 | 12 | |
| 6 | 2022 | 11 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 3 |
About Huawei Xia
Huawei Xia is a scholar working on Molecular Biology, Immunology, Pulmonary and Respiratory Medicine, Genetics and Infectious Diseases, having authored 8 papers that have together received 103 indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (2 papers), Inflammasome and immune disorders (2 papers), Immune cells in cancer (1 paper), Long-Term Effects of COVID-19 (1 paper), Nanoplatforms for cancer theranostics (1 paper), Inflammatory Bowel Disease (1 paper), Genetic and Kidney Cyst Diseases (1 paper) and Advanced Steganography and Watermarking Techniques (1 paper). The work is most often cited by research in Immunology (25 citations), Pulmonary and Respiratory Medicine (30 citations), Molecular Biology (54 citations), Cancer Research (11 citations) and Infectious Diseases (13 citations). Huawei Xia has collaborated with scholars based in China, Ethiopia and Italy. Frequent co-authors include Fuping You, Lili Cao, Qi Liang, Weizhi Nie, Yishan Su, Shengde Liu, Xiao Wang, Hongqiang Du, Jiachen Li and Qiulian Mao. Their work appears in journals such as iScience, Medicine, Viruses, Neural Processing Letters and Journal of Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.